Submucous uterine fibroids and pregnancy planning. Modern tactics

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Uterine fibroids (UF) are a common benign tumor of the female genital tract, diagnosed in almost a quarter of women of reproductive age. In case of infertility, UF is detected in 23.5% of cases. Submucosal localization of UF is the most common cause of infertility or pregnancy loss during reproductive age. There is also convincing evidence of the negative impact of UF with a submucosal node on the outcomes of in vitro fertilization (IVF). Currently, hysteroscopic myomectomy is considered the most effective treatment for submucosal UFs. Traditionally, monopolar and bipolar resectoscopes are used for this surgery. However, an increase in the frequency of postoperative complications after hysteroresectoscopy leading to a decrease in reproductive potential has also been noted: the formation of intrauterine synechiae up to total obliteration of the uterine cavity. In view of the fact, the relevance of various methods of preoperative preparation and postoperative management of patients with submucosal UF, aimed at reducing the incidence of complications, is increasing.

About the authors

A. S. Khachatryan

Yerevan State Medical University

Email: iliyina@mail.ru
ORCID iD: 0009-0000-2767-8995
Armenia, Yerevan

Yu. E. Dobrokhotova

Pirogov Russian National Research Medical University

Email: iliyina@mail.ru
ORCID iD: 0000-0002-7830-2290
Russian Federation, Moscow

Irina Y. Ilyina

Pirogov Russian National Research Medical University

Author for correspondence.
Email: iliyina@mail.ru
ORCID iD: 0000-0001-8155-8775

Dr. Sci. (Med.), Professor at the Department of Obstetrics and Gynecology, Faculty of Medicine

Russian Federation, Moscow

M. A. Alieva

Pirogov Russian National Research Medical University

Email: iliyina@mail.ru
ORCID iD: 0009-0007-0220-5164
Russian Federation, Moscow

D. M. Ibragimova

Yerevan State Medical University

Email: iliyina@mail.ru
ORCID iD: 0000-0002-8738-868X
Armenia, Yerevan

References

  1. Ciebiera M., Lozinski T., Wojtyla C., et al. Complications in modern hysteroscopic myomectomy. Ginekol Pol. 2018;89(7):398–404. doi: 10.5603/GP.a2018.0068.
  2. Миома матки. Клинические рекомендации. 2020. [Uterine fibroids. Clinical recommendations. 2020. (In Russ.)].
  3. Stewart E.A., et al. Epidemiology of uterine fibroids: a systematic review. BJOG: An Int J Obstet Gynaecol. 2017;124(10):1501–12. doi: 10.1111/1471-0528.14640.
  4. Zepiridis L.I., Grimbizis G.F., Tarlatzis B.C. Infertility and uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:66–73. doi: 10.1016/j.bpobgyn.2015.12.001.
  5. Parazzini F., Tozzi L., Bianchi S. Pregnancy outcome and uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:74–84. doi: 10.1016/j.bpobgyn.2015.11.017.
  6. Краснова И.А., Аксенова В.Б., Есипова И.А. и др. Гистероскопическая резекция субмукозной миомы матки. Вопросы медикаментозной подготовки. Вопросы гинекологии, акушерства и перинатологии. 2018;17(5):11–20. [Krasnova I.A., Aksenova V.B., Esipova I.A., et al. Hysteroscopic resection of submucous uterine fibroids. Issues of drug preparation. Issues Gynecol Obstet Perinatal. 2018;17(5):11–20. (In Russ.)].
  7. Фаткуллин И.Ф., Орлов Ю.В., Фаткуллин Ф.И. Современные подходы к тактике ведения беременности при миоме матки. Медицинский вестник Юга России. 2023;14(2):44–51. [Fatkullin I.F., Orlov Yu.V., Fatkullin F.I. Modern approaches to the tactics of pregnancy management in uterine fibroids. Med Bull South of Rus. 2023;14(2): 44–51. (In Russ.)].
  8. Миома матки: диагностика, лечение и реабилитация. Клинические рекомендации (протокол лечения). Акушерство и гинекология, 206;4. [Uterine fibroids: diagnosis, treatment and rehabilitation. Clinical recommendations (treatment protocol). Obstet Gynecol. 206;4. (In Russ.)].
  9. Бреусенко В.Г., Мишиева О.И., Караценцова И.В. и др. Место биполярной гистерорезекции в лечении больных с субмукозной миомой матки. Журнал акушерства и женских болезней. 2011;60(5):18–24. [Breusenko V.G., Mishieva O.I., Karacencova I.V., et al. The place of bipolar hysteroresection in the treatment of patients with submucous uterine fibroids. J Obstet Women’s Dis. 2011;60(5):18–24. (In Russ.)].
  10. Istre O. Management of symptomatic fibroids; conservative surgical treatment modalitic other than myomectomy. Best Pract Res Clin Obstet Gynecol. 2008;22(4):735–47.
  11. Доброхотова Д.Э., Ильина И.Ю. Миома матки у пациенток пременопаузального периода. Медицинский совет. 2019;13:123–28. [Dobrohotova D.E., Il’ina I.Yu. Uterine fibroids in premenopausal patients. Med Adv. 2019;13:123–28. (In Russ.)].
  12. Brady P.C. Stanic A.K. Uterine fibroids and subfertility: an update on the role of myomectomy. Curr Opin Obstet Gynecol. 2013;25(3):255–59. doi: 10.1097/GCO.0b013e3283612188.
  13. Munro M.G., et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynecol Obstet. 2018;143(3):393–408. doi: 10.1002/ijgo.12666.
  14. Kubik-Huch R.A., et al. European Society of Urogenital Radiology (ESUR) guidelines: MR imaging of leiomyomas. Eur Radiol. 2018;28(8):3125–37. doi: 10.1007/s00330-017-5157-5.
  15. Suzuki A., et al. Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma Using Magnetic Resonance Images: A Literature Review. Healthcare. Multidisciplin. Digital Publish. Institute. 2019;7(4):158. doi: 10.3390/healthcare7040158.
  16. Fascilla F.D., et al. Ultrasound diagnosis of uterine myomas. Minerva Ginecol. 2016;68(3):297–312.
  17. Доброхотова Ю.Э., Ильина И.Ю., Ибрагимо- ва Д.М., Нариманова М.Р. Миома матки: альтернативные методы лечения. Проблемы репродукции. 2018;24(2):83–7. [Dobrohotova Yu.E., Il’ina I.Yu., Ibragimova D.M., Narimanova M.R. Uterine fibroids: alternative treatment methods. Reproduct Probl. 2018;24(2):83–7. (In Russ.)].
  18. Полипы эндометрия. Клинические рекомендации. 2023. [Endometrial polyps. Clinical recommendations. 2023.].
  19. Bittencourt C.A., Dos Santos Simоes R., Bernardo W.M., et al. Accuracy of saline contrast sonohysterography in detection of endometrial polyps and submucosal leiomyomas in women of reproductive age with abnormal uterine bleeding: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2017;50(1):32–9. doi: 10.1002/uog.17352.
  20. Краснова И.А., Аксенова В.Б., Есипова И.А. и др. Гистероскопическая резекция субмукозной миомы матки. Вопросы медикаментозной подготовки. Вопросы гинекологии, акушерства и перинатологии. 2018;17(5):11–20. [Krasnova I.A., Aksenova V.B., Esipova I.A., et al. Hysteroscopic resection of submucous uterine fibroids. Issues of drug preparation Issues Gynecol Obstet Perinatal. 2018;17(5):11–20. (In Russ.)].
  21. Vitale S.G., Sapia F., Rapisarda A.MC., et al. Hysteroscopic Morcellation of Submucous Myomas: A Systematic Review. Biomed Res Int. 2017;2017:6848250. doi: 10.1155/2017/6848250.
  22. Erian M.M., McLaren G.R., Erian A.M. Advanced hysteroscopic surgery training. JSLS. 2014;18(4):e2014.00396. doi: 10.4293/JSLS.2014.00396.
  23. Berg A., Sandwick L., Landebrekke A., et al. A randomized trial comparing monopolar electrodes with two different types of bipolar electrodes. Fertil Steril. 2009;91(4):273–78. doi: 10.1016/j.fertnstert.2008.01.083.
  24. Сафронов О.В., Казачкова Э.А., Казачков Е.Л. и др. Клинико-морфологическая оценка эффективности амбулаторной гистероскопической миомэктомии. Мать и дитя в Кузбассе. 2022;3(90):117–25. [Safronov O.V., Kazachkova E.A., Kazachkov E.L., et al. Clinical and morphological assessment of the effectiveness of outpatient hysteroscopic myomectomy. Mother Child Kuzbass. 2022;3(90):117–25. (In Russ.)].
  25. Carranza-Mamane B., Havelock J., Hemmings R. Reproductive Endocrinology and Infertility Committee; Special Contributor. The management of uterine fibroids in women with otherwise unexplained infertility. J Obstet Gynaecol Can. 2015;37(3):277–85. doi: 10.1016/S1701-2163(15)30318.
  26. Джакупов Д.В., Кудайбергенов Т.К., Султано-ва Ж.У. и др. Гистерорезектоскопия в лечении субмукозной миомы матки. Репродуктивная медицина. 2019;3(40):56–9. [Dzhakupov D.V., Kudajbergenov T.K., Sultanova Zh.U., et al. Hysteroresectoscopy in the treatment of submucous uterine fibroids. Reprod Med. 2019;3(40):56–9. (In Russ.)].
  27. Haimovich S., Lopez-Yarto M., Urresta Avila J., et al. Office Hysteroscopic Laser Enucleation of Submucous Myomas without Mass Extraction: A Case Series Study. Biomed Res Int. 2015;255–61. doi: 10.1155/2015/905204.
  28. Чайка К.В., Писарева О.Л. Сравнительная характеристика эффективности комплексных методов органосохраняющего лечения у женщин с субмукозной миомой матки репродуктивного возраста. Репродуктивная медицина. 2014;3(4):78–81. [Chajka K.V., Pisareva O.L. Comparative characteristics of the effectiveness of complex methods of organ-preserving treatment in women with submucous uterine fibroids of reproductive age. Reprod Med. 2014;3(4):78–81. (In Russ.)].
  29. The Cochrane Collaboration. Uterine artery embolization for symptomatic uterine fibroids (Review). Published by John Wiley and Sons, Ltd. 2012.
  30. Анчар Е.П., Гурин А.Л., Костяхин А.Е. и др. Современные подходы лечения миомы матки с субмукозной локализаией узла. Актуальные проблемы медицины. 2018. С. 162–65. [Anchar E.P., Gurin A.L., Kostyahin A.E., et al. Modern approaches to the treatment of uterine fibroids with submucous node localization. Current problems of medicine. 2018:162–65. (In Russ.)].
  31. Хашукоева А.З., Сухова Т.Н., Рзаева Р.А., Мосешвили Г.Г. Новый метод консервативного лечения миомы матки. Лечащий врач. 2017;3:34. [Hashukoeva A.Z., Suhova T.N., Rzaeva R.A., Moseshvili G.G. A new method of conservative treatment of uterine fibroids. The attending physician. 2017;3:34. (In Russ.)].
  32. Леваков С.А., Шешукова Н.А. Влияние медикаментозной терапии мифепристоном на качество жизни пациенток с миомой матки. Медицинс-кий совет. 2017;2:136–41. [Levakov S.A., Sheshukova N.A. The effect of mifepristone drug therapy on the quality of life of patients with uterine fibroids. Med Adv. 2017;2:136–41. (In Russ.)].
  33. Лебедева Я.А., Молчанов О.Л., Байбуз Д.В., Галиуллина Л.А. Оценка качества жизни женщин репродуктивного возраста после лечения миомы матки с применением антигестагенов. Медицинский вестник Башкортостана. 2019;14:4(82):16–21 [Lebedeva Ya.A., Molchanov O.L., Bajbuz D.V., Galiullina L.A. Assessment of the quality of life of women of reproductive age after treatment of uterine fibroids with the use of antigestogens. Med Vestn Bashkortostanа. 2019;14:4(82):16–21. (In Russ.)].
  34. Доброхотова Ю.Э., Ильина И.Ю., Гончаров И.Ю. Миома матки. Безоперационное лечение. Русский медицинский журнал. Мать и дитя. 2018;26(2–1):3–6. [Dobrohotova Yu.E., Il’ina I.Yu., Goncharov I.Yu. Uterine fibroids. Non-surgical treatment. breast cancer. Mother Child. 2018;26(2–1):3–6. (In Russ.)].
  35. Alessandro C., Carlo A., Antonio M., Giuseppe D.P. The management of Asherman syndrome: a review of literature. Reprod Biol Endocrinol. 2013;11:118. doi: 10.1186/1477-7827-11-118.
  36. Онлас А.Р., Джакупов Д.В., Барманашева З.Е. Взгляд доказательной медицины на проблему внутриматочных синехий (обзор литературы). Вестник КазНМУ. 2016;3:265–75. [Onlas A.R., Dzhakupov D.V., Barmanasheva Z.E. The view of evidence-based medicine on the problem of intrauterine synechiae (literature review). Bull KazNMU. 2016;3:265–75. (In Russ.)].
  37. Deans R., Abbott J. Review of intrauterine adhesions. Jminim. Invasive Gynecol. 2010;17:555–69.
  38. Spiezio S., Spinelli М., Bramante S., et al. Efficacy of a polyethylene oxide-sodium carboxymethylcellulose gel in prevention of intrauterine adhesions after hysteroscopic surgery. J Minim Invasive Gynecol. 2011;18(4):462–69. doi: 10.1016/j.jmig.2011.04.007.
  39. Давыдов А.И., Пашков В.М., Шахламова М.Н. Субмукозная миома матки в сочетании с аденомиозом. Принципы таргетной терапии в репродуктивном периоде. Вопросы гинекологии, акушерства и перинатологии. 2019;18(3):124–32. [Davydov A.I., Pashkov V.M., Shahlamova M.N. Submucous uterine fibroids in combination with adenomyosis. Principles of targeted therapy in the reproductive period. Issues Gynecol Obstet Perinatal. 2019;18(3):124–32. (In Russ.)].
  40. Козаченко И.Ф., Адамян Л.В. Гистероскопия у пациенток с бесплодием: опыт использования противоспаечных барьеров. Акушерство и гинекология. 2023;4:147–52. [Kozachenko I.F., Adamyan L.V. Hysteroscopy in patients with infertility: the experience of using anti-adhesive barriers. Obstet Gynecol. 2023;4:147–52. (In Russ.)].
  41. Bosteels J., Weyers S., Mol B.W., D’Hooghe T. Anti-adhesion barrier gels following operative hysteroscopy for treating female infertility: a systematic review and meta-analysis. Gynecol Surg. 2014;11(2):113–27. doi: 10.1007/s10397-014-0832-x.
  42. Федоров А.А., Сопова Ю.И., Попов А.А. и др. Влияние миомэктомии на репродуктивные исходы. Российский вестник акушера-гинеколога. 2020;20(4):47–51. [Fedorov A.A., Sopova Yu.I., Popov A.A., et al. The effect of myomectomy on reproductive outcomes. Rus Bull Obstet-Gynecol 2020;20(4):47–51. (In Russ.)].
  43. Arendas K., Leyland N.A. Use of Ulipristal Acetate for the Management of Fibroid Related Acute Abnormal Uterine Bleeding. J Obstet Gynaecol Can. 2016;38(1):80–3. doi: 10.1016/j.jogc.2015.11.005.
  44. Тумабаева С.Д., Есенгулова А.М., Баймуханбетова Ж.Н. Оценка эффективности гистерорезектоскопии в лечении субмукозной миомы матки. Вестник КазНМУ. 2016;4:1–3. [Tumabaeva S.D., Esengulova A.M., Bajmuhanbetova Zh.N. Evaluation of the effectiveness of hysteroresectoscopy in the treatment of submucous uterine fibroids. Bull KazNMU. 2016;4:1–3. (In Russ.)].

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies